Eugene Laska
Overview
Explore the profile of Eugene Laska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1604
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laska E, Lin Z, Siegel C, Marmar C
Stat Anal Data Min
. 2024 Jul;
17(2).
PMID: 39036335
We introduce a simple variant of a Purely Random Forest, an Absolute Random Forest (ARF) for clustering. At splits of units are determined by a randomly chosen feature and a...
2.
Lin Z, Laska E, Siegel C
Stat Anal Data Min
. 2022 Sep;
15(4):433-446.
PMID: 36061078
The quality of a cluster analysis of unlabeled units depends on the quality of the between units dissimilarity measures. Data dependent dissimilarity is more objective than data independent geometric measures...
3.
Bogenschutz M, Ross S, Bhatt S, Baron T, Forcehimes A, Laska E, et al.
JAMA Psychiatry
. 2022 Aug;
79(10):953-962.
PMID: 36001306
Importance: Although classic psychedelic medications have shown promise in the treatment of alcohol use disorder (AUD), the efficacy of psilocybin remains unknown. Objective: To evaluate whether 2 administrations of high-dose...
4.
Ramos-Cejudo J, Genfi A, Abu-Amara D, Debure L, Qian M, Laska E, et al.
Psychiatr Res Clin Pract
. 2022 Feb;
3(4):153-162.
PMID: 35211666
Background And Objective: Posttraumatic stress disorder (PTSD) is a serious and frequently debilitating psychiatric condition that can occur in people who have experienced traumatic stessors, such as war, violence, sexual...
5.
Laska E, Siegel C, Lin Z
Contemp Clin Trials
. 2022 Jan;
114:106688.
PMID: 35085831
Objective: To further the precision medicine goal of tailoring medical treatment to individual patient characteristics by providing a method of analysis of the effect of test treatment, T, compared to...
6.
Siegel C, Laska E
Neuropsychopharmacology
. 2021 Jul;
47(1):379-380.
PMID: 34285371
No abstract available.
7.
Schultebraucks K, Qian M, Abu-Amara D, Dean K, Laska E, Siegel C, et al.
Mol Psychiatry
. 2020 Jun;
26(9):5011-5022.
PMID: 32488126
Active-duty Army personnel can be exposed to traumatic warzone events and are at increased risk for developing post-traumatic stress disorder (PTSD) compared with the general population. PTSD is associated with...
8.
R Lowe S, Ratanatharathorn A, Lai B, van der Mei W, Barbano A, Bryant R, et al.
Psychol Med
. 2020 Feb;
51(7):1129-1139.
PMID: 32008580
Background: Research exploring the longitudinal course of posttraumatic stress disorder (PTSD) symptoms has documented four modal trajectories (low, remitting, high, and delayed), with proportions varying across studies. Heterogeneity could be...
9.
Samuelson K, Newman J, Abu Amara D, Qian M, Li M, Schultebraucks K, et al.
Neuropsychology
. 2019 Dec;
34(3):276-287.
PMID: 31789568
Objective: The Fort Campbell Cohort study was designed to assess predeployment biological and behavioral markers and build predictive models to identify risk and resilience for posttraumatic stress disorder (PTSD) following...
10.
Adam A, Schwartz R, Wu L, Subramaniam G, Laska E, Sharma G, et al.
Addict Sci Clin Pract
. 2019 Oct;
14(1):39.
PMID: 31615549
Background: The TAPS Tool is a substance use screening and brief assessment instrument that was developed for use in primary care medical settings. It is one of the first screening...